192 related articles for article (PubMed ID: 30448482)
1. Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer.
Yang CJ; Shah SA; Lin BK; VanDusen KW; Chan DY; Tan WD; Ranney DN; Cox ML; D'Amico TA; Berry MF
Ann Thorac Surg; 2019 Apr; 107(4):1074-1081. PubMed ID: 30448482
[TBL] [Abstract][Full Text] [Related]
2. A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival.
Yang CJ; Nwosu A; Mayne NR; Wang YY; Raman V; Meyerhoff RR; D'Amico TA; Berry MF
Ann Thorac Surg; 2020 May; 109(5):1503-1511. PubMed ID: 31733187
[TBL] [Abstract][Full Text] [Related]
3. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
[TBL] [Abstract][Full Text] [Related]
5. Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes.
Galvaing G; Tardy MM; Cassagnes L; Da Costa V; Chadeyras JB; Naamee A; Bailly P; Filaire E; Pereira B; Filaire M
Ann Thorac Surg; 2014 May; 97(5):1708-13. PubMed ID: 24625436
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP
Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372
[TBL] [Abstract][Full Text] [Related]
8. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
9. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
Stokes SM; Massarweh NN; Stringham JR; Varghese TK
Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
[TBL] [Abstract][Full Text] [Related]
10. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
11. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer.
Deol PS; Sipko J; Kumar A; Tsalatsanis A; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2019 Aug; 166(2):211-217. PubMed ID: 31202473
[TBL] [Abstract][Full Text] [Related]
12. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
[TBL] [Abstract][Full Text] [Related]
13. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
[TBL] [Abstract][Full Text] [Related]
15. Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.
Yang CF; Gulack BC; Gu L; Speicher PJ; Wang X; Harpole DH; Onaitis MW; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1484-92; discussion 1492-3. PubMed ID: 26259994
[TBL] [Abstract][Full Text] [Related]
16. Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
Yamaguchi M; Shimamatsu S; Edagawa M; Hirai F; Toyozawa R; Nosaki K; Seto T; Takenoyama M; Ichinose Y
Surg Today; 2019 Mar; 49(3):197-205. PubMed ID: 30610361
[TBL] [Abstract][Full Text] [Related]
17. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
Amini A; Correa AM; Komaki R; Chang JY; Tsao AS; Roth JA; Swisher SG; Rice DC; Vaporciyan AA; Lin SH
Ann Thorac Surg; 2012 Sep; 94(3):914-20. PubMed ID: 22819472
[TBL] [Abstract][Full Text] [Related]
18. Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer.
Kumar A; Srinivasan D; Potter AL; Mathey-Andrews C; Lanuti M; Martin LW; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1895-1905.e2. PubMed ID: 37722622
[TBL] [Abstract][Full Text] [Related]
19. Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.
Mulvihill MS; Cox ML; Becerra DC; Watson JA; Voigt SL; Yerokun BA; Speicher PJ; D'Amico TA; Tong B; Hartwig MG
Ann Thorac Surg; 2018 Nov; 106(5):1533-1540. PubMed ID: 29959940
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
Maruyama R; Hirai F; Ondo K; Kometani T; Hamatake M; Seto T; Sugio K; Ichinose Y
Surg Today; 2011 Nov; 41(11):1492-7. PubMed ID: 21969151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
